Cord Blood 25-hydroxyvitamin D and Fetal Growth in the China-Anhui Birth Cohort Study

Peng Zhu1,2,3, Shi-lu Tong1,3, Wen-biao Hu3

  • 1Department of Maternal, Child &Adolescent Health, Anhui Medical University, Hefei, China.

Scientific Reports
|October 10, 2015
PubMed

Insights

Neonatal vitamin D levels show an inverted U-shaped link with fetal growth. Moderate vitamin D concentrations in newborns were associated with increased birth weight and reduced risk of small for gestational age (SGA).

Area of Science:

  • Maternal and Child Health
  • Nutritional Epidemiology
  • Neonatal Development

Background:

  • Vitamin D is crucial for fetal development.
  • The impact of neonatal vitamin D status on birth outcomes requires further investigation.
  • Small for gestational age (SGA) is a significant concern in neonatal health.

Purpose of the Study:

  • To determine the association between cord blood 25-hydroxyvitamin D [25(OH)D] levels and birth weight.
  • To investigate the relationship between cord blood 25(OH)D and the risk of small for gestational age (SGA).

Main Methods:

  • Prospective cohort study (China-Anhui Birth Cohort - C-ABC) involving 1491 neonates in Hefei, China.
  • Measurement of cord blood 25(OH)D levels.
  • Collection of data on maternal and neonatal characteristics and birth outcomes.
  • Application of multiple regression models to analyze associations.

Main Results:

  • Neonates in the 4th to 7th deciles of cord blood 25(OH)D had significantly higher birth weight and lower SGA risk compared to the lowest decile.
  • A non-linear, inverted U-shaped relationship was observed between cord blood 25(OH)D and birth weight.
  • Each 10 nmol/L increase in 25(OH)D was associated with a 61.0g increase in birth weight at levels <40 nmol/L, and a 68.5g decrease at levels between 40-70 nmol/L.

Conclusions:

  • This study provides the first epidemiological evidence of an inverted U-shaped relationship between neonatal vitamin D status and fetal growth.
  • Moderate concentrations of vitamin D in neonates are associated with improved fetal growth and reduced risk of SGA.
  • Optimal maternal vitamin D supplementation strategies may be important for fetal development.

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.2K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
6.0K